Digital therapeutics platforms for mental health are software‑driven, evidence‑based solutions that deliver therapeutic interventions for conditions such as depression, anxiety, and PTSD. They are increasingly pivotal as healthcare systems seek scalable, cost‑effective alternatives to traditional therapy. The Digital Therapeutics Platforms for Mental Health market size reached approximately $5.8 billion in 2025, and analysts project a compound annual growth rate (CAGR) of around 20% through the 2026‑2033 market forecast, underscoring a robust growth outlook and rapid industry expansion. Key macro drivers include heightened mental‑health awareness, expanding insurance reimbursement, and the acceleration of tele‑health adoption post‑COVID‑19. The sector is shaped by three dominant forces: (1) evolving regulatory pathways that grant clearer market entry criteria, (2) breakthroughs in AI‑enabled personalization that boost clinical efficacy, and (3) shifting consumer behavior favoring on‑demand, mobile‑first care. North America remains the largest market, while Asia‑Pacific is emerging as the fastest‑growing region.